Prominent Law Firm Bragar Eagel & Squire, P.C. Alerts Investors of Class Action Lawsuits Involving Cassava, NYCB, Amylyx, and InMode

New York City-based law firm Bragar Eagel & Squire, P.C., known for its dedication to protecting shareholder rights, has issued a reminder to investors of recent class action lawsuits initiated against a group of companies. The suits have surfaced on behalf of shareholders of various corporations, including biopharmaceutical company Cassava Sciences, Inc. SAVA, financial institution New York Community Bancorp, Inc. NYCB, Amylyx Pharmaceuticals, and medical technology company InMode Ltd. INMD. These actions stem from alleged unlawful business practices and potentially misleading information that may have affected stock values detrimentally.

About InMode Ltd. INMD

INMD, headquartered in Yokneam, Israel, is a visionary in the field of minimally invasive medical aesthetics. With an innovative suite of products based on RF-assisted lipolysis and deep subdermal fractional RF technologies, INMD has positioned itself as a leader in non-invasive cosmetic enhancements, providing options for customers looking for effective treatments with shorter recovery times.

About New York Community Bancorp, Inc. NYCB

As a prominent banking holding company, NYCB stands as the entity behind New York Community Bank, serving a broad customer base with a variety of banking products and services. This institution operates in key regions, including the bustling New York metropolitan area, New Jersey, Ohio, Florida, and Arizona. NYCB's headquarters is situated in Westbury, New York, serving as a central hub for its regional banking operations.

This reminder from Bragar Eagel & Squire, P.C. serves to prompt investors who have incurred losses from their investments in these companies to take appropriate legal action before deadlines pass. It underscores the firm's commitment to uphold the rights and interests of its investor clientele amid these unfolding legal situations.

lawsuit, investors, reminder